Detail Information of Exogenous Modulation
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0057 Transporter Info | ||||
Gene Name | ABCC11 | ||||
Transporter Name | Multidrug resistance-associated protein 8 | ||||
Gene ID | |||||
UniProt ID | |||||
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM) | |||||
---|---|---|---|---|---|
Chemical Compound |
|||||
DT Modulation1 |
Fulvestrant inhibits the reaction Estradiol results in decreased expression of ABCC11 mRNA | [2] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Tamoxifen inhibits the reaction Estradiol results in decreased expression of ABCC11 mRNA | [2] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation1 |
Tamoxifen inhibits the reaction Estradiol results in decreased expression of ABCC11 mRNA | [2] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation1 |
Valproic Acid results in decreased methylation of ABCC11 gene | [23] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation1 |
ABCC11 mRNA results in decreased abundance of Methotrexate | [8] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
ABCC11 mRNA results in decreased susceptibility to Methotrexate | [8] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation3 |
ABCC11 protein results in decreased susceptibility to Methotrexate | [9] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation1 |
ABCC11 protein results in decreased susceptibility to Fluorouracil | [2] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation1 |
Benzo(a)pyrene affects the methylation of ABCC11 promoter | [17] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
bisphenol A |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
bisphenol A co-treated with Fulvestrant results in increased methylation of ABCC11 gene | [18] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
CGP 52608 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
CGP 52608 promotes the reaction RORA protein binds to ABCC11 gene | [19] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Chenodeoxycholic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Triclosan co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid results in increased expression of ABCC11 mRNA | [20] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Deoxycholic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Triclosan co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid results in increased expression of ABCC11 mRNA | [20] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Docetaxel |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Docetaxel results in decreased susceptibility to Docetaxel which results in increased expression of ABCC11 mRNA | [21] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Fluorodeoxyuridylate |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
ABCC11 protein results in decreased susceptibility to Fluorodeoxyuridylate | [9] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
ABCC11 protein results in increased export of Fluorodeoxyuridylate | [9] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Fulvestrant |
3 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
bisphenol A co-treated with Fulvestrant results in increased methylation of ABCC11 gene | [18] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Fulvestrant inhibits the reaction Estradiol results in decreased expression of ABCC11 mRNA | [2] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation3 |
Fulvestrant results in increased methylation of ABCC11 gene | [18] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Glycochenodeoxycholic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Triclosan co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid results in increased expression of ABCC11 mRNA | [20] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Glycocholic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Triclosan co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid results in increased expression of ABCC11 mRNA | [20] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Glycodeoxycholic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Triclosan co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid results in increased expression of ABCC11 mRNA | [20] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
methyleugenol |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
methyleugenol results in decreased expression of ABCC11 mRNA | [14] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
N-Nitrosopyrrolidine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
N-Nitrosopyrrolidine results in decreased expression of ABCC11 mRNA | [14] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Okadaic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Okadaic Acid results in decreased expression of ABCC11 mRNA | [22] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Pemetrexed |
3 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
ABCC11 gene SNP affects the susceptibility to Pemetrexed | [8] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
ABCC11 mRNA results in decreased susceptibility to Pemetrexed | [8] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation3 |
ABCC11 protein results in decreased susceptibility to Pemetrexed | [8] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Triclosan |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Triclosan co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid results in increased expression of ABCC11 mRNA | [20] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Approved Drug |
|||||
Estradiol |
3 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Estradiol inhibits the expression of ABCC11 | [2] | |||
Tamoxifen |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Tamoxifen increases the expression of ABCC11 | [2] | |||
Amiodarone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Amiodarone increases the expression of ABCC11 | [3] | |||
Zidovudine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Zidovudine increases the expression of ABCC11 | [4] | |||
Valproic Acid |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Valproic Acid affects the expression of ABCC11 | [5] | |||
Rifampin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Rifampin increases the expression of ABCC11 | [6] | |||
Urethane |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Urethane inhibits the expression of ABCC11 | [7] | |||
Methotrexate |
4 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Methotrexate induces the activity of ABCC11 | [8] | |||
Fluorouracil |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Fluorouracil induces the activity of ABCC11 | [9] | |||
Drug in Phase 2 Trial |
|||||
Genistein |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Genistein increases the expression of ABCC11 | [10] | |||
Investigative Drug |
|||||
Cyclic AMP |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Cyclic adenosine monophosphate inhibits the transportation of Cyclic guanosine monophosphate by ABCC11 | [1] | |||
Affected Drug/Substrate |
Cyclic guanosine monophosphate | Modulation Type | Inhibition | ||
Cell System |
LLC-PK1 vesicles-MRP8 | ||||
Natural Product |
|||||
Methyleugenol |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Methyleugenol inhibits the expression of ABCC11 | [14] | |||
Mycotoxins |
|||||
Aflatoxin B1 |
3 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Aflatoxin B1 inhibits the expression of ABCC11 | [11] | |||
DT Modulation2 |
Aflatoxin B1 results in decreased methylation of ABCC11 intron | [15] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation3 |
Aflatoxin B1 results in increased methylation of ABCC11 gene | [16] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Acute Toxic Substance |
|||||
Cadmium |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Cadmium inhibits the expression of ABCC11 | [12] | |||
Carcinogen |
|||||
Benzo(a)pyrene |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Benzo(a)pyrene inhibits the expression of ABCC11 | [14] | |||
Health and Environmental Toxicant |
|||||
tris(1,3-dichloro-2-propyl)phosphate |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
tris(1,3-dichloro-2-propyl)phosphate inhibits the expression of ABCC11 | [13] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.